Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10021302rdf:typepubmed:Citationlld:pubmed
pubmed-article:10021302lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C0205065lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C0039286lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C0279752lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C1709372lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C0205207lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:10021302lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:10021302pubmed:issue2lld:pubmed
pubmed-article:10021302pubmed:dateCreated1999-3-11lld:pubmed
pubmed-article:10021302pubmed:abstractTextTamoxifen is the antihormonal treatment of choice for premenopausal breast cancer patients with advanced breast disease. Its premenopausal administration has been shown to induce supraphysiological 17beta-estradiol serum levels and to be associated with the presence of persistent, bilateral functional ovarian cysts. However, these abnormalities have not yet been compared to controls. In this study we evaluated the possibility that the above hormonal and/or ovarian abnormalities are more frequent among premenopausal breast cancer patients treated with tamoxifen than among similar nontreated patients, and thus they may be attributed to tamoxifen effect.lld:pubmed
pubmed-article:10021302pubmed:languageenglld:pubmed
pubmed-article:10021302pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10021302pubmed:citationSubsetIMlld:pubmed
pubmed-article:10021302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10021302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10021302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10021302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10021302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10021302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10021302pubmed:statusMEDLINElld:pubmed
pubmed-article:10021302pubmed:monthFeblld:pubmed
pubmed-article:10021302pubmed:issn0090-8258lld:pubmed
pubmed-article:10021302pubmed:authorpubmed-author:CohenIIlld:pubmed
pubmed-article:10021302pubmed:authorpubmed-author:BeythYYlld:pubmed
pubmed-article:10021302pubmed:authorpubmed-author:TepperRRlld:pubmed
pubmed-article:10021302pubmed:authorpubmed-author:ShapiraJJlld:pubmed
pubmed-article:10021302pubmed:authorpubmed-author:AltarasM MMMlld:pubmed
pubmed-article:10021302pubmed:authorpubmed-author:YigaelDDlld:pubmed
pubmed-article:10021302pubmed:authorpubmed-author:FigerAAlld:pubmed
pubmed-article:10021302pubmed:copyrightInfoCopyright 1999 Academic Press.lld:pubmed
pubmed-article:10021302pubmed:issnTypePrintlld:pubmed
pubmed-article:10021302pubmed:volume72lld:pubmed
pubmed-article:10021302pubmed:ownerNLMlld:pubmed
pubmed-article:10021302pubmed:authorsCompleteYlld:pubmed
pubmed-article:10021302pubmed:pagination202-7lld:pubmed
pubmed-article:10021302pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:meshHeadingpubmed-meshheading:10021302...lld:pubmed
pubmed-article:10021302pubmed:year1999lld:pubmed
pubmed-article:10021302pubmed:articleTitleOvarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.lld:pubmed
pubmed-article:10021302pubmed:affiliationDepartment of Obstetrics and Gynecology, Sapir Medical Center, Kfar-Saba, Israel.lld:pubmed
pubmed-article:10021302pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10021302pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10021302pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10021302lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10021302lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10021302lld:pubmed